A serum‐free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines
- 1 May 1994
- journal article
- Published by Wiley in The Prostate
- Vol. 24 (5) , 221-228
- https://doi.org/10.1002/pros.2990240502
Abstract
This paper describes a serum‐free defined medium (Gc) that was initially designed to support growth of the human prostatic carcinoma cell line LNCaP. Our studies indicate that this medium formulation is capable of supporting short‐term, long‐term, and clonal growth of the LNCaP cell line. Component deletion experiments have shown that the three most critical components for LNCaP short‐term growth are insulin, triiodothyronine (T3), and fetuin. Additionally, this medium was found to support short‐term and clonal growth of three other human prostatic carcinoma cell lines, DU 145, PC‐3, and ALVA‐31. The availability of such a medium should aid in the distinction of the regulatory factors involved in growth and differentiation of malignant prostatic epithelium.Keywords
This publication has 33 references indexed in Scilit:
- Human primary prostate tumor cell line, ALVA‐31: A new model for studying the hormonal regulation of prostate tumor cell growthThe Prostate, 1993
- Regulation of fibroblast growth factor-like protein(s) in the androgen-responsive human prostate carcinoma cell line LNCaPThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- IGF-I and IGF-Binding Proteins: Stimulatory and Inhibitory Factors Secreted by Human Prostatic Adenocarcinoma CellsGrowth Factors, 1991
- Regulation of gene expression by the thyroid hormone receptorBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Prostate cancer in blacks: An update from the American college of surgeons' patterns of care studiesJournal of Surgical Oncology, 1989
- Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroidsInternational Journal of Cancer, 1988
- Insulin-Like Growth Factor (IGF)&slash;Somatomedin Receptor Subtypes: Structure, Function, and Relationships to Insulin Receptors and IGF Carrier ProteinsHormone Research, 1986
- Analysis of the mitogenic effect of fetuin preparations on arterial smooth muscle cells: The role of contaminant platelet‐derived growth factorJournal of Cellular Physiology, 1985